𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of K-ras/p53 mutations in stool specimens of patients with colorectal cancer

✍ Scribed by Hattori, Takashi; Kaminaga, Norihiro; Endo, Yutaka; Hiroshi, Takahashi; Fujita, Rikiya

Book ID
122661430
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
180 KB
Volume
114
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Detection of K-ras mutations in stools o
Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR
✍ Peter Nollau; Carsten Moser; GΓΌnter Weinland; Christoph Wagener πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 639 KB

Mutant-enriched PCR was applied to the detection of mutations at codons I 2 and I 3 of K-ras genes in the stools of patients with colorectal cancer. Mutations were analyzed in stool samples obtained prior to surgery. Resected tumor specimens were screened for K-ras mutations by PCR-mediated RFLP ana

Utilization of K-ras mutations identifie
Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer
✍ ZΓ¨ev Lev; Dmitry Kislitsin; Gad Rennert; Aaron Lerner πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

Colorectal cancer is one of the most common malignancies in the western world. About 60,000 Americans die of colorectal cancer each year. The annual incidence rate in Israel is 40 per 100,000 persons, namely a total of 2,000 new cases each year. An important step in the progression of colorectal can

Mutation analysis of p53, K-ras, and BRA
Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression
✍ Daniele Calistri; Claudia Rengucci; Ian Seymour; Arturo Lattuneddu; Anna maria P πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract Gene mutations in __APC__, __K‐ras__, and __p53__ are thought to be essential events for colorectal cancer development. Recent data seem to indicate that __K‐ras__ and __p53__ mutations rarely co‐exist in the same tumor, indicating that these alterations do not represent a synergistic e